Compared to non-metastatic patients, the GREM2 and CTSS genes exhibited significantly higher expression levels, while TINAGL1, ACKR1, and HLA-DRB1 showed a tendency to increase in metastatic soft tissue sarcoma (SS); however, these differences were not statistically significant. The gene discussed is CTSS; the disease is soft tissue sarcoma.